Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Cellular Trafficking in Asthma in Response to Segmental Allergen Challenge

NCT00595491 is registered in ClinicalTrials.gov with Benjamin Medoff as lead sponsor.

NCT NCT00595491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Cellular Trafficking in Asthma in Response to Segmental Allergen Challenge
Lead sponsor
Benjamin Medoff
Phase
Phase 1
Overall status
Recruiting
Start date
January 31, 2008
Completion date
January 31, 2029
Enrollment
313 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma